Association of Circulating microRNAs in Plasma with Coronary Collateral Circulation in Patients with Chronic Total Occlusion.

Eighteen miRNAs were differentially expressed in EDTA plasma and 13 in citrate plasma across the study comparisons.

• Small RNA sequencing was performed on the NextSeq 550 (1 × 75 bp) with QIAseq miRNA UDI libraries.
• The study ran in parallel on two plasma types, K2EDTA and sodium citrate.
• Total RNA was isolated with the miRNeasy Serum/Plasma Advanced Kit.
• Abstract does not specify which comparisons produced which DE miRNAs beyond the good vs poor CCC result.

Only one miRNA, hsa-miR-92a-3p in citrate plasma, was differentially expressed between CTO patients with good and poor coronary collateral circulation.

• Good CCC (n = 13) and poor CCC (n = 10) were defined by the Rentrop classification.
• No such good-vs-poor difference is reported in EDTA plasma in the abstract.
• The result is described as hypothesis-generating.

The study was an exploratory analysis with a small sample of 43 patients in three groups.

• Controls had no significant coronary artery stenosis (n = 20).
• CTO groups were good CCC (n = 13) and poor CCC (n = 10).
• The authors state that, given the limited sample size, findings need validation in larger, independent cohorts.

The authors conclude that further studies are required to validate these miRNAs and establish their roles in CCC development.

• Findings are framed as hypothesis-generating.
• Validation is needed in larger, independent cohorts.

CTO occurs in 16-52% of patients with coronary artery disease and is accompanied by variable development of coronary collateral circulation.

• This is the background rationale for studying circulating miRNAs as correlates of CCC.